ALLK Allakos Inc.
37.68
+2.52 (+7%)
Previous Close
35.16
Open
35.54
Price To Book
8.1
Market Cap
1586820063
Shares
42,113,059
Volume
304,663
Short Ratio
Av. Daily Volume
365,219
NewsSee all news
- Allakos Announces Positive Phase 1 Results with AK002 in Indolent Systemic Mastocytosis
- Allakos Enters Oversold Territory
- Allakos Announces Positive Phase 2 Results for AK002 in Patients with Xolair Refractory Chronic Spontaneous Urticaria and Provides Additional Data from Chronic Urticaria Study Cohorts
- Allakos to Host Investor Day on February 19 in New York City
- Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism
SEC filingsSee all SEC filings
Drug Information
Drug catalyst information is displayed when you hover over the stage bar graph.
Phase 1 data released February 19, 2019.
AK002
Indolent Systemic Mastocytosis
Phase 2 additional data released February 11, 2019. 9% UAS7 complete responder rate.
AK002
Chronic Urticaria
Latest News
- Allakos Announces Positive Phase 1 Results with AK002 in Indolent Systemic Mastocytosis
- Allakos Enters Oversold Territory
- Allakos Announces Positive Phase 2 Results for AK002 in Patients with Xolair Refractory Chronic Spontaneous Urticaria and Provides Additional Data from Chronic Urticaria Study Cohorts
- Allakos to Host Investor Day on February 19 in New York City
- Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism
- Allakos Announces Positive Phase 2 Results in a Cohort of Xolair-Naïve Chronic Spontaneous Urticaria Patients
- Here are the winners and losers from Bay Area's IPO class of 2018
- 5 Best-Performing IPOs of 2018
- Assessing the Performance of 2018’s Major IPOs
- Allakos (ALLK) Catches Eye: Stock Jumps 6.5%
- Here's how much better insiders have profited from this year's IPO boom
- Has Allakos Inc (NASDAQ:ALLK) Got Enough Cash?
- Mixed Reviews For Allakos As Sell-Side Starts Coverage Of Biotech
SEC Filings
- 8-K - Current report 19614332
- 8-K - Current report 19613467
- SC 13G - Statement of acquisition of beneficial ownership by individuals 19599266
- SC 13G - Statement of acquisition of beneficial ownership by individuals 19594510
- 8-K - Current report 19581942
- 8-K - Current report 19561655
- 8-K - Current report 19547153
- 8-K - Current report 19512230
- 10-Q - Quarterly report [Sections 13 or 15(d)] 181170244
- 8-K - Current report 181169675